- Shih DM, Kast-Woelbern HR, Wong J, Xia Y-R, Edwards PA and Lusis AJ: A role for FXR and human FGF-19 in the repression of paraoxonas1 gene expression by bile acids.Journal of Lipid Research 47, 384–392 (2006)
- Lundasen T, Galman C, Angelin B. and Rudling M: Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.Journal of Internal Medicine 260, 530–536 (2006)
- Kurose H, Okamoto M, Shimizu M, Bito T, Marcelle C, Noji S and Ohuchi H: FGF-19-FGFR4 signaling elaborates lends induction with the FGF8-L-Maf cascade in the chick embryo.Develop. Growth Differ. 47, 213–223 (2005)
- Fu L, John LM, Adams SH, Yu XX, Tomlinson E, Renz M, Williams PM, Soriano R, Corpuz R, Moffat B, Vandlen R, Simmons L, Foster J, Stephan JP, Tsai SP, Stewart TA: Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes.Endocrinology 145, 2594–2603 (2004)
- Strack AM and Myers RW: Modulation of metabolic syndrome by fibroblast growth factor 19 (FGF-19)? Endocrinology 145, 2591–2593 (2004), Review
- Holt JA, Luo G, Billin AN, Bisi J, McNeill YY, Kozarsky KF, Donahee M, Wang DY, Mansfield TA, Kliewer SA, Goodwin B and Jones SA: Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis.Genes and Development 17, 1581–1591 (2003)
- Tomlinson E, Fu L, John L, Hultgren B, Huang X, Renz M, Stephan JP, Tsai SP, Powell-Braxton L, French D and Stewart TA: Transgenic mice expressing human fibroblast grwth factor-19 display increased metabolic rate and decreased adiposity.Endocrinology 143, 1741–1747 (2002)
- Ornitz DM and Itoh N: Fibroblast growth factors.Genome Biology 2(3), 3005.1–3005.12 (2001), Review
Shopping cart $0
Search